Primary Record
Coenzyme Q9
- In stock
- 8,292 g
- Purity
- 98.3 %
- CAS
- 303-97-9
Compound Identifiers & Properties
- CAS
- 303-97-9
- PubChem CID
- 5280473
- SMILES
- CC1=C(C(=O)C(=C(C1=O)OC)OC)C/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CCC=C(C)C
- Canonical SMILES
- COC1=C(OC)C(=O)C(C/C=C(\C)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CCC=C(C)C)=C(C)C1=O
Names & Synonyms
- Coenzyme Q9
- Ubiquinone 9
- Ubiquinone-9
- Ubiquinone 45
- Ubiquinone Q9
- CoQ9
- Ubiquinone-45
- 303-97-9
- ubiquinone Q-9
- Coenzyme Q(sub 9)
- Ubiquinone9
- Ubiquinone Q(sub 9)
- CoQ(sub 9)
- coenzyme-Q9
- ubiquinone(9)
- Coenzyme Q(9)
- Coenzyme Q9?
- MGW7TYF2DQ
- COENZYMEQ9
- UNII-MGW7TYF2DQ
- AC1NQX2M
- Coenzyme Q9 (Standard)
- RefChem:127404
- Ubidecarenone EP Impurity D
- DTXSID601317880
- MFCD00056635
- Ubidecarenone impurity D CRS
- UBIQUINONE Q9 (STN)
- C54H82O4
- CHEBI:18160
- UUGXJSBPSRROMU-WJNLUYJISA-N
- orb1301680
- CHEMBL2252965
- Coenzyme Q9 from Candida utilis
- NSC 226993
- NSC-226993
- SCHEMBL27472926
- Ubidecarenone Related Compound A
- BRN 1900081
- DTXCID60909085
- Ubiquinone Q9;CoQ9;Ubiquinone 9
- ZINC8217487
- EX-A14857
- LMPR02010004
- MSK158298
- NSC226993
- AKOS027307694
- C54-H82-O4
- CID5280473
- Coenzyme Q9, >=96.0% (HPLC)
- CS-6359
- EBC-106040
- FC20538
- HY-101415R
- Ubidecarenone Impurity 1(Coenzyme Q9)
- CID:5280473
- AS-77794
- J11.404I
- LS-40351
- SID:87225397
- SY074807
- HY-101415
- FT-0665153
- ubiquinone 9, (Z,Z,Z,Z,Z,E,E,E)-isomer
- 4-08-00-03313 (Beilstein Handbook Reference)
- Coenzyme Q9, 99.8% - 100MG 100mg
- J1.205.858F
- UBIDECARENONE IMPURITY D [EP IMPURITY]
- C01967
- C030571
- F787628
- UBIDECARENONE RELATED COMPOUND A [USP-RS]
- 2,3-Dimethoxy-5-methyl-6-((2E,6E,10E,14E,18E,22E,26E,30E)-3,7,11,15,19,23,27,31,35-nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaen-1-yl)cyclohexa-2,5-diene-1,4-dione
- 2,3-dimethoxy-5-methyl-6-[(2E,6E,10E,14E,18E,22E,26E,30E)-3,7,11,15,19,23,27,31,35-nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaenyl]cyclohexa-2,5-diene-1,4-dione
- A1025684
- 2-methyl-3-nonaprenyl-5,6-dimethoxy-1,4-benzoquinone
- Q27102857
- 2,3-dimethoxy-5-methyl-6-[(2E,6E,10E,14E,18E,22E,26E,30E)-3,7,11,15,19,23,27,31,35-nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaen-1-yl]cyclohexa-2,5-diene-1,4-dione
- 2,5-cyclohexadiene-1,4-dione, 2,3-dimethoxy-5-methyl-6-((2E,6E,10E,14E,18E,22E,26E,30E)-3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaen-1-yl)-
- B2699-305013
- 2,5-Cyclohexadiene-1,4-dione, 2,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaenyl)-, (all-E)-
- p-Benzoquinone, 2,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaenyl)-
- p-Benzoquinone, 2,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaenyl)- (VAN)
- Ubidecarenone impurity D, European Pharmacopoeia (EP) Reference Standard
- Ubidecarenone Related Compound A, United States Pharmacopeia (USP) Reference Standard
- (all-E)-2,3-Dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaenyl)-2,5-cyclohexad iene-1,4-dione
- (all-E)-2,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaenyl)-2,5-cyclohexadiene-1,4-dione
- 2,3-dimethoxy-5-methyl-6-((2E,6E,10E,14E,18E,22E,26E,30E)-3,7,11,15,19,23,27,31,35-nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaenyl)cyclohexa-2,5-diene-1,4-dione
- 2,3-Dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31,35-nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaen-1-yl)cyclohexa-2,5-diene-1,4-dione
- 2,3-Dimethoxy-5-methyl-6-[(2E,6E,10E,14E,18E,22E,26E,30E)-3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanenonenyl]-2,5-cyclohexadiene-1,4-dione
- 2,3-dimethoxy-5-methyl-6-[(2E,6E,10E,14E,18E,22E,26E,30E)-3,7,11,15,19,23,27,31,35-nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaen-1-yl]-1,4-benzoquinone
- 2,3-dimethoxy-5-methyl-6-[(2E,6E,10E,14E,18E,22E,26E,30E)-3,7,11,15,19,23,27,31,35-nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaenyl]-1,4-benzoquinone
- 2,3-Dimethoxy-5-methyl-6-[(2E,6E,10E,14E,18E,22E,26E,30E)-3,7,11,15,19,23,27,31,35-nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonene-1-yl]-2,5-cyclohexadiene-1,4-dione
- 2,4-dione, 2,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaenyl)-, (all-E)-
- 2-[(2E,6E,10E,14E,18E,22E,26E,30E)-3,7,11,15,19,23,27,31,35-Nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonenyl]-5,6-dimethoxy-3-methyl-2,5-cyclohexadiene-1,4-dione
- 3-Methyl-5,6-dimethoxy-2-(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonene-1-yl)-1,4-benzoquinone
- p-Benzoquinone,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaenyl)-
- Q-9
- Ubiquinone Q9; Ubiquinone 9; CoQ9; NSC 226993; 2,3-dimethoxy-5-methyl-6-[(2E,6E,10E,14E,18E,22E,26E,30E)-3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaen-1-yl]-2,5-Cyclohexadiene-1,4-dione; Coenzyme Q9; 2,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaenyl)-p-Benzoquinone; Ubidecarenone EP impurity D